Christopher Kane
Verified
As seen in:
The Capitol Forum,
Medium,
Yahoo Life,
Forbes,
Nature,
Reuters,
The Guardian,
Wiley,
Wiley Online Library,
Aol,
British Journal of Pain
and
Covers:
M&A, merger review/ clearance, antitrust litigation, DOJ, FTC, HHS, FDA, health policy developments, pharmaceuticals, fintech
Senior Correspondent at The Capitol Forum covering antitrust and the White House in Trump's second term: ckane@thecapitolforum.com | chris.541 on Signal
Get in touch with Christopher
Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Christopher Kane’s Biography
Read Full Bio →Reporter: healthcare, pharmaceuticals, antitrust for Policy and Regulatory Report (PaRR) and Dealreporter (Acuris publications)
Former contributing writer at the Los Angeles Blade
Christopher Kane’s Journalist Portfolio
Spark/Roche refiles possibly responding to FTC intra-commission tensions—former FTC officials
Wright/Stryker working on joint finger, ankle antitrust divestiture, sources say
Texas may join other states in Sprint/T-Mobile suit